APA (7th ed.) Citation

MP, L., N, A., G, B., H, B., C, B., T, D., . . . M, K. (2026). Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216). British journal of cancer, 134(1), 85. https://doi.org/10.1038/s41416-025-03188-x

Chicago Style (17th ed.) Citation

MP, Lutz, et al. "Predictive Criteria for Overall Survival and Treatment Duration of 2nd-line Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma (AIO-PAK-0216)." British Journal of Cancer 134, no. 1 (2026): 85. https://doi.org/10.1038/s41416-025-03188-x.

MLA (9th ed.) Citation

MP, Lutz, et al. "Predictive Criteria for Overall Survival and Treatment Duration of 2nd-line Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma (AIO-PAK-0216)." British Journal of Cancer, vol. 134, no. 1, 2026, p. 85, https://doi.org/10.1038/s41416-025-03188-x.